Vol. 118, No. 1, 1984
AND BIOPHYSICAL RESEARCH COMMUNlCATlONS Pages 217-224
BIOCHEMICAL
January 13, 1984
THE APPEARANCE OF PHOSPHOLIPASE ACTIVITY IN THE HUMAN MACROPHAGE-LIKE CELL LINE U937 DURING DIMETHYL SULFOXIOE INDUCED DIFFERENTIATION Robin Department
Received
F. Myers
of Allergy 60 Orange
December
and Marvin
I.
and Inflammation, Street, Bloomfield,
Siegel Schering Plough NJ 07003
Co.,
1, 1983
The human histiocyte cell line, U937, with monocyte --Sunnnary: characteristics, can be induced to differentiate into macrophage-like cells when exposed to growth medium containing 1.5% DMSO. Following three days of exposure, DMSO-treated but not control U937 cells can be stimulated to release endogenous arachidonic acid from their phospholipids. Maximum release of the unsaturated fatty acid occurs with 10 uM calcium ionophore in the presence but not in the absence of exogenously added calcium ion. In addition, DMSO-treated but not control U937 ccl 1 S exhibit phospholipase activity when exposed to human IgG and then anti-human inmunoglobulin. These data suggest that with respect i nto to arachidonic acid metabolism U937 cells differentiate functional macrophage-like cells when exposed to DMSO.
A human hematopoietic patient
with
Nilsson
in 1976
suspension monocytic stepwise described
cell
generalized (1)
These (1)
and,
morphological for research
induced
to differentiate
macrophage-like lectin-stimulated 1 mM dibutyryl The abbreviations heptadecatrienoic iocasatetraenoic icosatetraenoic
cells
when
cells
induced
into
that
CAMP (2,4-61.
maintained
cells
chemotactic
peptide
to medium
a
to that
(2,31. line
can be
sensitive
conditioned
to 1.3% dimethyl In addition
undergo
similar
U937 cell
and
imnature
to differentiate,
monocytic
a
in
to represent
the
by exposure
from
by Sundstrom
maturation
normal
lymphocytes,
used acid acid; acid,
successfully appear
has indicated
was established
lymphoma
and functional
differentiating
Further
(U937)
histiocytic
and has been
culture. cells
line
sulfoxide
to chemotaxis,
by or to the
are: HHT, 12-hydroxy-5,8,10,: 5-HETE. 5-hvdroxv-6.8.11.14-LTB 5s 12R-d i’ hy‘hroxyi6,8,10,14leuk%&ieAe B4. 0006-291X/84 Copyright
217
All
rights
0 1984 of reproduction
$1.50
by Academic Press, Inc. in any fiwm reserved.
Vol. 118, No. 1, 1984
BIOCHEMICAL
abilities
to produce
superoxide
enzymes
and to perform
been
induced
line, various
Since acid
normal
when
serve
DMSO-induced This
report
antibody
these
fatty
from
their
acid
of this
model
of
of normal
human
promyelocytic
differentiation
endogenous
leukemia
release in U937 cells
The induction
following
of U937 cells
reported growth
it
was
to release
phospholipids. activity
could
as has been previously
appearance
stimulatable
the previously
(8-151,
cell
line
to a granulocyte-like the
phospholfpids
arachidonfc
agonists
phospholfpase
of differentiation
the
complex
cells
have
the U937 cell
endogenous
appropriate ability
differentiation. with
the the
describes
endogenous
parameters
metabolize
with
the expression
with
cytolysis
to be a useful
to investigate
as a marker
observed
cellular
Therefore,
appears
macrophages
the unsaturated Moreover,
lysozomal
function.
stimulated
of interest
(4,7).
and biochemical
monocyte-macrophage
to release
dependent
agents
neoplastfc,
biological
anion,
antibody
by these
although
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
cell
of calcium
in functional
in DMSO containing
and
acid
from
DMSO-induced
of such an activity increase
(16).
ionophore
of arachfdonic during
HL60 following
is consistent responses medium
of
(4).
MATERIALS AND METHODS: Cells. The U937 cells were a generous ~fromDr.KX~ore?JX.i.ie University. The U937 cell line was cultured in RPMI 1640 with 10% heat inactivated fetal bovine serum (lot 100389, Sterile Systems, Logan UT), penicillin (50 units/ml), streptomycin (50 ug/ml), 1% MEM non-essential amino-acids, 1% sodium pyruvate and 1% L-glutamine (all from Cell cultures wgre split so6that the Gibco, Grand Island, NY). cell density was maintained between 2 x 10 and 2 x 10 cells/ml. Cells were induced to differentiate by the addition of DMSO to a final concentration of 1.5% to the above culture medium. wf;h;;p@;;pase Ass_a3r!, Cell cultures were incubated overnight arac1Taonlc acid (Amersham, 55 uCf/umole) at a concentration of 2 uM (0.1 uCf/mll. Labelled cells were harvested by centrffugation and washed twice with 50 mM Trfs-HCl buffer, pH 7.4, containing 100 mM NaCl. Washed cells were resuspended in 50 mM Tris-HCl buffer, pH 7.4, containing 100 mM The cell suspensions (1 ml) NaCl, 1 mM CaCl f, and 1 mM glucose. were incubated t 37 for various times as indicated in the Reactions were terminated by the addition of 2.4 figure legends. ml chloroform:methanol (1:l v/v) and 10 ul of 10% formic acid. The samples were cooled in ice and centrifuged. The organic 218
BIOCHEMICAL
Vol. 118, No. 1, 1984
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
layer was withdrawn and evaporated to dryness under a steady stream of N The dry extract was then redissolved in a small volume of c P‘1oroform:methanol (1:2 v/v) and spotted on silica thin layer plates (sil 625, without gypsum, Brinkmann). Chromatograms were developed with an ascending solvent system composed of the upper layer of ethylacetate:iso-octane:glacial acetic acid:water (90:50:20:100 v/v/v/v~. Labelled products were located by autoradiography and the appropriate regions of the chromatograms were scraped and counted in a liquid scintillation counter. Products were identified by co-chromatography with authentic standards. All assays were in duplicate and have been repeated at least twice. Values are plus or minus 10% of the mean. Since negligible metabolism of released arachidonic acid occurred, phospholipase activity was determined by measuring the free arachidonic acid produced upon stimulation. RESULTS: --
U937 cells
to divide
after
Figure
control
approximately
every
rate
divide
by the
three
cultures
is
not
As illustrated
second
day of exposure
as measured
significantly
in
double
DMSO-treated
Viability,
however,
days.
1.5% DMSO cease
hours,
by the
third.
containing
of U937 cells
seventeen
of division
exclusion,.
in medium
approximately
1, while
their
grown
in density
cells
slow and cease
by trypan
affected
to
blue
(data
not
shown). This
halt
in cell
increased
ability
acid
endogenous
from
while
both
arachidonic
acid
U937 cells
do not
presence
medium
release
ionophore
activity
activity
corresponds
DMSO-treated
ionophore
from DMSO treated
but
dependent.
As shown
A23187
maximal
with
21.
in Figure
fatty
three
cells
acid
control when exposed
grown
in the
days express
The induction
this
of this
of growth
2,
incorporate
phospholipids,
However,
at least
(Fig.
arachidonic
readily
unsaturated
to the cecession
cultures
The calcium
their
A23187.
(Fig.
by an
to release
cells
into
the
reflected
As illustrated
and DMSO-treated from
is
cells
phospholipids.
of 1.5% DMSO for
phospholipase
and division
of DMSO-treated
control
to the calcium
growth
enzymatic
observed
in
1). stimulated
not control in Figure
arachidonic
release U937 cells
3, DMSO-treated acid 219
release
of arachidonic
acid
is concentration cells occurring
respond at a
to
Vol. 118, No. 1, 1984
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
---
of U937 cells in DMSO containing medium. U937 --Fig. 1. Growth cells were grown in suspension culture in the absence (o) or presence (01 of 1.5% DMSO as described in Materials and Methods. The number of cells in the culture was rneaYlZE!Xly. Asdetermined by trypan blue exclusion, viability was greater than 95% in control and DMSO containing cultures throughout the times shown. Fig. 2. Appearance of nhospholipase activity in DMSO treated IlW7Fells. U937 cells were grown as described in Fig. 1 in the absence (01 or presence (0) of 1.5% DMSO. At the times indicated, cells were assayed for 2 minutes for the oresence of phospholipase activity as described in Materials and Methods I'n thel$resence of 10 uM A2 IncorporXXniXf----ClClarachidonic acid 3&!z'cellular lipids was greater than 80% in control and 60% in DMSO-treated cells14fter overnight labelling. The amount flf esterified5[1C$rachidonic acid in the assays wgs 8.0 x 10 50 1.7 x610 dpm/lO cells for control and 1.1 x 10 to 2.5 x 10 dBm/lO cells for DMSO-treated cells. Assays contained 4 - 10 x 10 cells. Results are reported as the per cent of esterified arachidonic acid released.
concentration
of
cells
do
not
their
endogenous
ionoohore
quantity times
release
phospholipids
induced
Maximal
of unesterified (Fig.
4).
of
approximately
amounts
10
uM.
Control
of arachidonic
at concentrations
acid
from
of the calcium
as 20 uM.
ionophore
process.
ionophore significant
as high
Calcium rapid
the
This
release
release
occurs
arachfdonic decline
is
of arachidonic in two minutes acid
apparently 220
declining
acid with
is
a the
at longer
due to the re-esteri-
BIOCHEMICAL
Vol. 118, No. 1, 1984
Calcium ionophore concentration dependence of acid release Control (a) and 4 day DMSO-treated 10) assayed ior their ability to release endogenous wer [l-e4 C7arachidonic acid in the presence of 1 mM CaC12 concentrations of the calcium ionophore A23187, as in Fig. 2.
%&donic U937 cells esterified and various described Fig. 4. treated absence described
fication
Time course of arachidonic acid release. U937 cells for 4 days with DMSO were assayed in the presence 10) (e) of 10 uM A23197 in the presence of 1 mM C&l2 as in Fig. 2.
of the unsaturated
metabolism LTB4 is
observed
A23187
41.
(Fig.
Ionophore
induced
upon exogenous
ion concentration by
acid
with
are detected
A23187
free
is
HHT, 5-HETE
in
In the absence
of free
(Fig.
increased,
occurs.
is 51.
is
release
calcium
ion
concentrations
complexes
are
natural
of
dependent calcium
in
observed
in the
However,
as the
significant
Optimal
of
absence
the
acid
activity
phospholipase of arachidonic between
0.5
5).
Antigen-antibody function
of DMSO-treated
but
consistent
those
with
(12,13,15,171. not
stimulators
As a measure
control
U937 cells
of normal
macrophaqes,
221
or
quantities
of arachidonic
of 10 uM A23187
or
negligible
Insignificant
no phospholipase
calcium
since
to prostaqlandins,
acid
ion.
or presence
stimulation
acid
shown).
release
absence
2.0 mM (Fig.
not
calcium
assay medium,
occurs
acid
(data
arachidonic
macrophage
fatty
of arachidonic
unesterified
the
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
of
of the
to express cells
were
ability
activities tested
and
Vol. 118, No. 1, 1984
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
-v Y ‘-PI i / O-o-@-*-e 0.5
1.0
I.5
2.0
[Co Cl21 , mM
%iinA assayed
for
their
Dependence of arachidonic acid release on exogenous ion. U937 cells treated for 4 davs with DMSO were as described in Fig. 2 in the presence (0) or absence for 2 minutes at various concentrations of
response
illustrated
to IgG-anti-IgG
in Figure
complex
formation.
6, OMSO treated
cells,
to human IgG and then
anti-human
release
from
phospholipids
their
endogenous
phospholipase complex
is
IgG alone cells
their
(data
not
DISCUSSIO& subject
activatable acid
necessary
from
In addition, arachidonic pathways
for
not
grown
endogenous
release
arachidonic
acid
(Fig.
when
burst
6).
exposed
of
IgG-anti-IgG
of this
in DMSO - do not lipids
first
of the
the expression
As
when exposed
in a rapid
The formation
does not cause
- those
from
the
activity.
IgG,
activity,
since
In addition, release to
(01
control acid
arachidonic IgG
and
anti-IgG
shown).
Arachidonic
acid
metabolism
of extensive
research
phospholipase,
which
membrane
releases
phospholipids,
macrophages acid
recently
via
in macrophages (8-15,
17).
to metabolize
the cycle-oxygenase
(8-10,12,15,18-20). 222
An
the unsaturated
has been described
are known
has been
(13,
unesterified
and lipoxygenase
fatty 18-201.
BIOCHEMICAL
Vol. 118, No. 1, 1984
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
IqG-anti-IqG stimulated arachidonic acid release a&t-treated U937 cells were preincubated for one houi a:"!;' with 1 mg/ml human IqG (Sigma) in RPM1 1640 and then washed and resuspended in 50 rr+l Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 1 mM CaCl and 1 mM glucose. The preincubated cells were assayed in the b resence (01 or absence (01 of 1 mq/ml anti-human IqG (Sigma) for the times indicated as described in Materials ------and Methods. -The present acid
metabolic
been
induced
study
describes
activity,
the appearance
phospholipase,
to differentiate
in U937 cells
by exposure
of a phospholipase
activity
cells
prevent
of endogenous
arachidonic
acid
functional
cycle-oxygenase dependent
ability
release
of normal
and peptide
growth
receptors
of U937 cells this
arachidonic
acid
metabolizing
previously
reported
that
be metabolized
challenge
of these
is
these
products.
have been
with
metabolic
zymosan, 223
(12,13,201, specific
is
in these
by
DMSO or dibutyryl induction
cells.
added
by control opsonized
only
surface
shown to be induced
of the
exogenously
mediated
of arachidonic
medium,
report
to prostaglandins cells
and
While
enzyme while
esterified
macrophages
the first
U937
or lipoxygenase
in conditioned
CAMP (2,4-6,211,
could
in undifferentiated
metabolism
cells.
have
sulfoxide.
to immunoglobulin
and subsequent
in the DMSO cultured
antigens
upon
to respond
a characteristic
present
the
the
by the
acid,
via
activities
For example, signals
metabolism
which
to dimethyl
The absence would
of an arachidonic
It
of an has been
arachidonic
acid
U937 cells, zymosan,
phorbol
Vol. 118, No. 1, 1984 myristate A23I87
BIOCHEMICAL
acetate, failed
acid cells
findings.
(221.
and its
The fact
can respond
line
may serve
arachidonic
PGE2 synthesis The lack
induction that
to activators
and IgG-anti-IgG
complex as a useful
acid
IgG or calcium ionophore
aggregated
to stimulate
arachidonic control
heat
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
metabolism
from
endogenous
of phospholipase
activity
by DMSO (Fig.
DMSO-treated
but
2) explains
not control
such as the calcium formation model
suggests for
in
ionophore that
studying
in human macrophage
these
U937 cells A23I87
the U937 cell
the role
of
function.
REFERENCES --_I_
1. 2. 3. 4.
and K. Nilsson (1976) Int. J. Cancer 17,565-577. S. J. Anderson and J. W. Larrick (1979rNature279,328-331. M. Pack, P. Bougnoux, Z. L. Chang and T. Hoffman (1983) J. Clin. Invest. 72, 237-244. G. E. Kay, B. C. Lane and-R. Synderman (1983) Infection and
C. Sundstrom H.S. Koren, T. Hattori,
Imnunity 41, 1166-1174. 5. 6. 7. 8. l’a. 11. 12. 13. 14. 15.
D. G. Fisher, M. C. Pike, H. S. Koren and R. Synderman (1980) J. Imnunol. 125, 463-465. M. C. Pike, 0. G. mer, H. S. Koren and R. Synderman (1980) J. Exp. Med. 152, 31-40. J, W. Larrick, D. G.TTscher, S. J. Anderson and H. S. Koren (1980) J. Imnunol. 125, 6-12. C. A. Rouzer, W. A.-Ott, A. L. Hamill and Z. A. Cohn (1982) J. Exp. Med. 155, 720-733. B. Rutherford and H.-A. Schenkein (1983) J. Innnunol. 130,874-877. S. L. Kunkel, K. Kaercher, M. Plewa, J. C. Fantone and Ward (1982) Prostaglandins 24, 789-799. A.O.S. Fells, N. A. Pawloski; E. B. Cramer, T.K.C. King, Z. A. Cohn and W. A. Scott (1982) Proc. Natl. Acad. Sci. USA
79, 7866-7870. J. A. Rankin, M. Hitchcock,
W. Merrill, M. K. Bach, J. R. Brashler and P. W. Askenase (1982) Nature 297, 329-331. C. A. Rouzer, W. A. Scott, A. L. Hamill, F.. Liu, D. H. Katz and Z. A. Cohn (1982) Proc. Natl. Acad. Sci. USA 79,5656-5660. M. V. Doig and A. W. Ford-Hutchinson (1980) Prostaglanmns20,1007-1019. w. Hsueh and F. F. Sun (1982) Biochem. Biophys. Res. Comnuni
106, 1985-1091. 16. 17. 18. 19. 20. 21.
22.
R.. Bonser, M. I. Siegel, R. T. McConnell and P. Cuatrecasas (1981) Biochem. Biophys. Res. Commun. 98,614-620. W. Hsueh, U. Desai, F. Gonzalez-Crussi, R. Lamb anifA. Chu (19811 Nature 290, 710-713. C. A. Rouzer, rA. Scott, J. Kempe and Z. A. Cohn (1980) Proc. Natl. Acad. Sci. USA 77, 4279-4282. W. A. Scott, J. M. Zrike, AX. Hamill, J. Kempe and Z. A. Cohn (1980) J. Exp. Med. 152, 324-335. W. A. Scott, C. A. Rouzer-Xd Z. A. Cohn (1983) Fed. Proc.g,129-133. K. Nilsson, K. Forsbeck, M. Gidlund, C. Sundstrom, T. Totterman, J. Sallstrom and P. Venge in Haematology and Blood Transfusion 26 (Neth, Gallo, Graf, Mannweiler and Winkler, eds.1, 215-221, 1981. M. A. Cobb, W. Hsueh, L. M. Pachman and W. T. Barnes (1983) J. Reticuloendothelial Sot. 33, 197-206.
224